N4 Pharma Share Price (N4P)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
N4 Pharma	LSE:N4P	London	Ordinary Share	GB00BYW8QM32	ORD 0.4P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	+2.10p	+17.14%	14.35p	5,339,690	16:29:07

Bid Price		Offer Price	High Price	Low Price	Open Price
14.10p		14.60p	14.85p	11.875p	12.25p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology		-1.93	-1.26		13.1

Related Shares
GlaxoSmithKline (GSK), AstraZeneca (AZN), Venn Life (VENN), Port Erin (PEBI)

N4 Pharma (N4P) Latest News

N4 Pharma News

Date	Time	Source	Headline
08/11/2018	16:40	UKREG	N4 Pharma PLC Second Price Monitoring Extn
08/11/2018	16:35	UKREG	N4 Pharma PLC Price Monitoring Extension
08/11/2018	14:05	UKREG	N4 Pharma PLC Second Price Monitoring Extn
08/11/2018	14:00	UKREG	N4 Pharma PLC Price Monitoring Extension
05/11/2018	11:06	UKREG	N4 Pharma PLC Second Price Monitoring Extn
05/11/2018	11:00	UKREG	N4 Pharma PLC Price Monitoring Extension
05/11/2018	09:19	ALNC	N4 Pharma Shares Jump On Pact Extension With AstraZeneca Unit
05/11/2018	09:00	UKREG	N4 Pharma PLC Price Monitoring Extension
05/11/2018	07:59	ALNCF	Alliance News Flash Headline
05/11/2018	07:54	UKREG	N4 Pharma PLC Research collaboration update

More N4 Pharma News

N4 Pharma Takeover Rumours

N4 Pharma (N4P) Share Charts

1 Year N4 Pharma Chart

1 Month N4 Pharma Chart

Intraday N4 Pharma Chart

N4 Pharma (N4P) Discussions and Chat

N4 Pharma Forums and Chat

Date	Time	Title	Posts
12/11/2018	17:21	N4 Pharma	1,371
03/9/2018	14:34	N4 Pharma - Making good drugs better.	3,884

Add a New Thread

N4 Pharma (N4P) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
16:27:01	14.44	13,713	1,980.16	O
16:23:29	14.49	69,013	9,999.98	O
16:22:44	14.04	5,000	701.75	O
16:22:31	14.11	8,413	1,187.07	O
16:20:34	14.15	24,816	3,511.99	O

View all N4 Pharma trades in real-time

N4 Pharma (N4P) Top Chat Posts

Date	Subject
12/11/2018 08:20	N4 Pharma Daily Update: N4 Pharma is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker N4P. The last closing price for N4 Pharma was 12.25p. N4 Pharma has a 4 week average price of 4.63p and a 12 week average price of 3.35p. The 1 year high share price is 35.50p while the 1 year low share price is currently 3.35p. There are currently 90,962,537 shares in issue and the average daily traded volume is 2,631,058 shares. The market capitalisation of N4 Pharma is £13,053,124.06. Read Full Thread Reply
12/11/2018 04:34	hughwilson: featherby81 As much as it pains me to walk away from a fight, I do understand where you are coming from. You may have noted from a few posts back where I said that as much of the positive news for N4 was now near term that I was inclined to let the company news do the talking. In my opinion the news for N4 is going to be highly positive in the near term and that will result in a share price that is many multiples of where we are now in due course, so for the time being I will play it your way and resist from posting and allow the debate to focus on all the near term news which I expect will be highly positive for the company and its share price. And to end, no I am not David Farier, nor for Lewis did I ever say I was , but I am aware of his business activities in turnaround situations like this from which he is normally very successful. Just something else the mob got wrong. Read Full Thread Follow Reply
11/11/2018 15:28	hughwilson: What I would like to see is an apology from all those posters who have been trying to deramp this stock during its time of uncertainty. Deramping by spreading lies and fear for their own personal gain to the detriment of real investors (myself included), that is the apology that I would like to see but that has about as much chance of platting fog. Lewis, I am confident in your ability in such a way that if I ever said will be an easy tweak then you would have found it. The fact that you have not been able to proves that it does not exist which is what I said and makes you a filthy liar along with all the other things you claim I said and did not. Your inability to prove to the contrary shows you up for the hateful vendetta that you have been waging against my person. In my opinion along with other investors is that it is time to move on from these personal vendetta`s. Given the vile and defamatory remarks I have suffered on this board I have more to be aggrieved about than most and yet my main interest remains the future of N4 which I see as being very positive with a share price of many multiples of where we are now. The future is looking extremely bright for N4 and that is now being recognized in the press and the share price. hTTps://www.thisismoney.co.uk/money/investing/article-6372161/SMALL-CAP-MOVERS-MySQUAR-edge-collapse-uncovering-900k-unauthorised-payments.html Read Full Thread Follow Reply
10/11/2018 15:35	hughwilson: So getting back to the point, does this sound like a deal is being discussed and that a deal is likely within the next three months? That question goes out to all except Lewis because he is just a Hugh hater. If you agree that there is a real chance of a deal then in your experience what is the effect on the share price when a minoe like N4 signs a deal with a major like AZ? "agreeing terms for co-development of an optimized version of Nuvec(R) under an appropriate collaboration agreement." In my experience, we have seen rises of 200-300% even before the market opens. Who knows what will happen here but as I said before, AZ are not the only company that N4 are in discussion with. If you accept that interest in Nuvec is building then you know where the share price is heading. Read Full Thread Follow Reply
10/11/2018 12:21	hughwilson: There is a post on twitter which I will share because it sums up the reality at this time. Thanks to the poster. #N4P - "I firmly believe that by focusing our resources on Nuvec® we are in fact giving N4 Pharma the greatest chance to achieve multiple commercial opportunities given the revised risk profile we faced with our generics division following the data obtained from our clinical trial." It was a change in the risk profile which led to the closure of the generics division but in doing so Nigel was giving Nuvec the best chance of success and multiples of today's share price. Read Full Thread Follow Reply
27/9/2018 09:45	ch1rp: At current mcap, and in light of recent deals in this subsector, it's really not unreasonable to suggest that a single (and entirely realistic) RNS could see the share price do multiples.Market needs educating on this.Aim Chaos on Twitter:)))Buy when no confidence and share price low, not on the day the news arrives:))) Read Full Thread Follow Reply
07/9/2018 15:45	artyth2: OK, so Nigel isn't allowed to give us any "insider information" We are not asking for any. But, where is he hiding? Why no statements.?......"everything going to plan or not", whatever. I've basically written Sildenafil off, so any comeback is a bonus, but Nuvec, surely we deserve some loose statements as to how its fairing, without breaching any protocol. He was very quick to allow information out to smash the share price but seems loath to help get the share price back on its feet. Second hand info, spoon fed from Mr Hugh Wilson, aka David Farrier and Aim Chaos, aka Myles Mcnulty isn't good enough. Read Full Thread Follow Reply
10/8/2018 12:19	jimbobaroony: Hugh, back in Feb when you were very bullish over N4P you accused me of deramping and posting "negative dribble". See below; "hughwilson7 Feb '18 - 20:12 - 1835 of 3883 As I said before, the Sildenafil is a reformulation of a proven drug to make it better. There is no basis for thinking N4's Viagra will be anything but successful. hughwilson7 Feb '18 - 21:53 - 1851 of 3883 The company itself is very bullish on its prospects. The company is ahead of its own timescales. It is already doing deals with the biggest pharmas in the world while being recognised snd funded by the British government. There are no negatives that I can see here and yet you spout nothing else but unsuported negative dribble. Don't pretend to be anything else (but a deramper)." This was becase I dared post the following suggesting that either could hammer the share price. "jimbobaroony 7 Feb '18 - 20:59 - 1843 of 3883 Edit For some yin to all your yang. Another catalyst (to drive share price).... - Delays / problems with their products - No deal announcements Pretty sure this is unlikely but its a possibility." I don't know how you can have the audacity to call us stupid!!! I am not in any way gloating at what has transpired (i am underwater here), however, it was always a possibility. Either you were too blind to see it, or didn't care as you had another agenda. Its one or the other! Read Full Thread Follow Reply
03/2/2018 08:53	nick2412: Hugh, I guess the wording translates as MedImmune / AZ have the right to discuss and seek exclusivity whilst N4P retain the right to name their price. I think it would require a very large initial milestone payment for an exclusive license, or, alternatively, necessitate buying Nuvac outright for a sum that equates in the N4P share price to pounds rather than pence for AZ (or any other company for that matter) to achieve exclusivity. The studiy highlighting the differences between Nuvac and current / other DNA /RNA drug delivery methods should be published this quarter and perhaps before the Japan visit. Existing findings suggest that Nuvac will be in demand so the potential is a)a lucrative exclusive deal with AZ b) multiple licensing deals with different partners c) a bidding war to buy Nuvac outright. Early days but it's looking interesting to say the least. Read Full Thread Follow Reply
03/7/2017 17:23	bdog51: I'm with you on that Flash. When the direction of travel reverses, the N4P share price can really motor. Bargain price down at these low levels right now. Just takes a bit of news flow to change the tide. Read Full Thread Follow Reply
18/5/2017 11:50	someuwin: CEO owns 17% of the equity here. This is almost entirely from his own purchases on the market when this was ONZ (see repeated Holdings RNSs last year). Furthermore his consideration shares resulting from the new N4P listing are deferred until the N4P share price has been over 15p for 10 consecutive days. ...I don't think it will be too long before that situation occurs. Read Full Thread Follow Reply

N4 Pharma share price data is direct from the London Stock Exchange

add chat code

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:41 V: D:20181112 18:20:02